Page 1

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement , make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement . CSPC CSPC PHARMACEUTICAL GROUP LIMITED 石 藥 集團 有限公司 ( Incorporated in Hong Kong with limited liability ) ( Stock code : 1093 ) QUARTERLY RESULTS FOR THE NINE MONTHS ENDED 30 SEPTEMBER 2021 FINANCIAL HIGHLIGHTS For the nine months ended 30 September 2021 RMB'000 ( Unaudited ) 2020 RMB'000 ( Unaudited ) Change Revenue by business units : Finished drugs 16,801,668 15,712,874 6.9 % Bulk products - Vitamin C 1,617,435 1,438,454 12.4 % - Antibiotics and others 1,234,626 995,536 24.0 % Functional food and others 988,024 1,068,349 -7.5 % Total revenue 20,641,753 19,215,213 7.4 % Profit attributable to shareholders 4,335,303 3,518,054 23.2 % RMB cents RMB cents Earnings per share - Basic - Diluted 36.26 29.43 23.2 % 36.26 29.42 23.2 % −1–